FindTrial
Sign In

Normal Coronary Artery With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-up

Normal Coronary Artery With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-up

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00960817
Enrollment
Unknown
Registered
2009-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2009-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Angiography

Keywords

Normal coronary artery with slow blood flow

Brief summary

The investigators will investigate patients undergoing coronary angiography with normal coronary but slow blood flow that was normalized after adenosine injection into the coronary artery. The investigators believe that they have small vessel coronary disease which is the initial presentation of coronary disease prior to anatomical narrowing. To alleviate this phenomenon the investigators intend to examine the long-term clinical response of these patients to treatment with dipyridamole, a well-known medication with almost no side-effects that increases the level of adenosine in the tissue.

Interventions

DRUGStatin, aspirin
DRUGDipyridamole

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing coronary angiography and who have normal coronary artery with slow blood flow that normalized with adenosine injection into the coronary artery

Exclusion criteria

* Significant coronary disease * Unstable patients * Patients with known sensitivity to dipyridamole

Design outcomes

Primary

MeasureTime frame
Alleviation of chest painTwo years

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026